Dr. Pedro Baula, MD

NPI: 1780755645
Total Payments
$214.35
2019 Payments
$26.70
Companies
4
Transactions
13

Payment Breakdown by Category

Food & Beverage$214.35 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $214.35 13 100.0%

Top Paying Companies

Company Total Records Latest Year
Shire North American Group Inc $121.37 7 $0 (2018)
GlaxoSmithKline, LLC. $46.38 3 $0 (2019)
Sanofi Pasteur Inc. $33.79 2 $0 (2018)
Merck Sharp & Dohme Corporation $12.81 1 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2019 $26.70 2 GlaxoSmithKline, LLC. ($13.89)
2018 $80.84 5 Shire North American Group Inc ($47.15)
2017 $106.81 6 Shire North American Group Inc ($74.22)

All Payment Transactions

13 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
12/14/2019 GlaxoSmithKline, LLC. BEXSERO (Biological), PEDIARIX, FLUARIX Food and Beverage In-kind items and services $13.89 General
Category: VACCINES
04/22/2019 Merck Sharp & Dohme Corporation ROTATEQ (Biological), VAQTA, GARDASIL9 Food and Beverage In-kind items and services $12.81 General
Category: VACCINE
11/13/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $17.47 General
Category: NEUROSCIENCE
11/06/2018 Sanofi Pasteur Inc. MENACTRA (Drug), PENTACEL, ADACEL Food and Beverage In-kind items and services $19.02 General
Category: VACCINES
09/05/2018 GlaxoSmithKline, LLC. BEXSERO (Biological), MENVEO Food and Beverage In-kind items and services $14.67 General
Category: VACCINES
08/21/2018 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $11.43 General
Category: NEUROSCIENCE
01/30/2018 Shire North American Group Inc MYDAYIS (Drug) Food and Beverage In-kind items and services $18.25 General
Category: NEUROSCIENCE
09/12/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $22.94 General
Category: NEUROSCIENCE
05/23/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $17.19 General
Category: NEUROSCIENCE
05/16/2017 GlaxoSmithKline, LLC. MENVEO (Biological), PEDIARIX, BOOSTRIX Food and Beverage In-kind items and services $17.82 General
Category: VACCINES
02/21/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $17.82 General
Category: NEUROSCIENCE
01/31/2017 SANOFI PASTEUR INC. MENACTRA (Drug), PENTACEL, FLUZONE Food and Beverage In-kind items and services $14.77 General
Category: VACCINES
01/24/2017 Shire North American Group Inc VYVANSE (Drug) Food and Beverage In-kind items and services $16.27 General
Category: NEUROSCIENCE

About Dr. Pedro Baula, MD

Dr. Pedro Baula, MD is a Pediatrics healthcare provider based in Elizabethtown, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780755645.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pedro Baula, MD has received a total of $214.35 in payments from pharmaceutical and medical device companies, with $26.70 received in 2019. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($214.35).

Practice Information

  • Specialty Pediatrics
  • Location Elizabethtown, KY
  • Active Since 11/13/2006
  • Last Updated 07/09/2007
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1780755645

Products in Payments

  • VYVANSE (Drug) $103.12
  • MENACTRA (Drug) $33.79
  • BEXSERO (Biological) $28.56
  • MYDAYIS (Drug) $18.25
  • MENVEO (Biological) $17.82
  • ROTATEQ (Biological) $12.81

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in Elizabethtown